Related Experiment Video
Updated: Nov 1, 2025

04:32
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
7.9K
GPIb-IX-V and platelet clearance
1Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.
Platelets
|June 23, 2021
Summary
The platelet glycoprotein Ib-IX-V is crucial for platelet survival and clearance. Its dysregulation contributes to bleeding disorders by affecting platelet removal mechanisms.
Area of Science:
- Hematology
- Cell Biology
- Vascular Biology
Background:
- Platelet adhesion to vascular damage sites is vital for hemostasis.
- The platelet glycoprotein (GP) Ib-IX-V complex mediates adhesion via von Willebrand Factor (VWF).
- GPIb-IX-V also influences platelet survival and clearance from circulation.
Purpose of the Study:
- To review the physiological and pathological mechanisms of platelet clearance.
- To highlight the central role of GPIb-IX-V in platelet clearance pathways.
- To discuss how GPIb-IX-V dysregulation contributes to bleeding disorders.
Main Methods:
- Literature review focusing on platelet adhesion, survival, and clearance.
- Analysis of the role of GPIb-IX-V in various clearance mechanisms.
- Examination of bleeding disorders associated with dysregulated platelet clearance.
Main Results:
- GPIb-IX-V is essential for platelet survival and maintaining normal platelet counts.
- It mediates clearance through glycan receptors, VWF-platelet complexes, and transfused platelets.
- Dysfunction of GPIb-IX-V is linked to thrombocytopenia in von Willebrand disease and immune thrombocytopenia.
Conclusions:
- GPIb-IX-V plays a multifaceted role in platelet homeostasis beyond adhesion.
- Understanding GPIb-IX-V-mediated clearance is critical for diagnosing and treating bleeding disorders.
- Targeting GPIb-IX-V pathways may offer therapeutic strategies for platelet count regulation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
791
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
791
Formation of the Platelet Plug
7.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.9K
Structure and Function of Platelets
2.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K

